Bharat Biotech Krishna Ella Japan India city Hyderabad covid-19 vaccine Immunic Bharat Biotech Krishna Ella Japan India city Hyderabad

Covid-19 vaccine: Japan approves Covaxin booster dose for travellers

Reading now: 554
www.livemint.com

Covaxin, Japan also recognizes Pfizer's Comirnaty, AstraZeneca's Vaxzevria, Moderna's Spikevax, Janssen's JCOVDEN, and Novavax's Nuvaxovid.

Last month, the Hyderabad-based company announced that the administration of the third dose of its Covid-19 vaccine Covaxin (BBV152) after six months of two-dose vaccination dramatically increased neutralizing antibody responses, and showed increased memory B cell response in subjects in controlled clinical trials.

The company said the findings are based on a comprehensive study that has demonstrated multiple benefits of Covaxin. According to Bharat Biotech, the vaccine provides benefits like long-term immune response, cell-mediated immunity, the safety of booster dose, and immunogenicity against spike protein.

Bharat Biotech said immune responses declined at six months but increased by 40-fold in subjects who received a booster dose.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA